Venture Life Group PLC (VLG) Receives “Buy” Rating from Panmure Gordon

Panmure Gordon reiterated their buy rating on shares of Venture Life Group PLC (LON:VLG) in a report released on Wednesday morning. They currently have a GBX 128 ($1.67) price objective on the stock.

Separately, Beaufort Securities restated a speculative buy rating on shares of Venture Life Group PLC in a research note on Monday, August 1st.

Venture Life Group PLC (LON:VLG) opened at 54.50 on Wednesday. The firm’s market cap is GBX 20.07 million. Venture Life Group PLC has a one year low of GBX 43.00 and a one year high of GBX 81.92. The stock has a 50 day moving average price of GBX 51.54 and a 200 day moving average price of GBX 56.26.

About Venture Life Group PLC

Venture Life Group PLC is a United Kingdom-based consumer self-care company. The Company focuses on developing, manufacturing and commercializing products for the ageing population. Its product range includes medical devices (such as those for minor aches and pains, and alleviating symptoms associated with hemorrhoids and itchy skin), food supplements (such as those for lowering cholesterol and improving brain function), and dermo-cosmetics and cosmetics for addressing the signs of skin-ageing.

Receive News & Ratings for Venture Life Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Venture Life Group PLC and related companies with's FREE daily email newsletter.

Leave a Reply

© 2006-2016 Mideast Time.